Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹9Cr
Chemicals - Calcium Carbonate
Rev Gr TTM
Revenue Growth TTM
-37.57%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

LIMECHM
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | -36.3 | -18.9 | -48.5 | -30.2 | -30.4 | -6.5 | 5.8 | 0.4 | -30.5 | -39.1 | -38.7 | -41.1 |
| 3 | 4 | 2 | 3 | 2 | 3 | 2 | 3 | 2 | 2 | 2 | 2 |
Operating Profit Operating ProfitCr |
| -2.1 | -8.9 | -5.3 | -10.0 | -4.7 | 4.3 | -2.9 | 1.5 | -15.2 | -8.7 | -11.0 | -5.9 |
Other Income Other IncomeCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
Growth YoY PAT Growth YoY% | 86.1 | -362.5 | -266.7 | -102.1 | 21.4 | 171.4 | 54.5 | 200.0 | 154.6 | -80.0 | -220.0 | -233.3 |
| -4.1 | -6.5 | -4.9 | -2.3 | -4.7 | 4.9 | -2.1 | 2.3 | 3.7 | 1.6 | -11.0 | -5.2 |
| -0.2 | -0.3 | -0.2 | -0.1 | -0.1 | 0.2 | -0.1 | 0.1 | 0.1 | 0.0 | -0.3 | -0.1 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| -29.9 | 47.1 | 55.1 | 17.9 | -15.8 | -28.2 | -28.9 | -36.6 | 10.1 | -32.5 | -7.5 | -33.0 |
| 20 | 24 | 37 | 43 | 40 | 31 | 23 | 15 | 15 | 11 | 10 | 7 |
Operating Profit Operating ProfitCr |
| -5.0 | 14.0 | 16.2 | 16.2 | 7.9 | 1.3 | -2.8 | -7.3 | 1.1 | -7.3 | -1.5 | -10.2 |
Other Income Other IncomeCr | 4 | 0 | 0 | 1 | 1 | 1 | 2 | 11 | 3 | 0 | 1 | 1 |
Interest Expense Interest ExpenseCr | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| 1 | 4 | 5 | 8 | 3 | -1 | 0 | 10 | 3 | 0 | 0 | 0 |
| 0 | 0 | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 |
|
| -66.0 | 241.3 | 53.9 | 51.9 | -65.8 | -112.1 | 142.6 | 7,140.1 | -71.9 | -117.8 | 145.0 | -167.8 |
| 5.0 | 11.6 | 11.5 | 14.8 | 6.0 | -1.0 | 0.6 | 69.7 | 17.8 | -4.7 | 2.3 | -2.3 |
| 3.0 | 10.1 | 14.4 | 19.0 | 4.3 | -0.5 | 0.5 | 15.1 | 4.2 | -0.8 | 0.3 | -0.3 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 3 | 3 | 3 | 5 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| -40 | -37 | -32 | -22 | -17 | -17 | -17 | -7 | -4 | -5 | -5 | -5 |
Current Liabilities Current LiabilitiesCr | 14 | 12 | 55 | 48 | 30 | 34 | 24 | 13 | 11 | 9 | 8 | 7 |
Non Current Liabilities Non Current LiabilitiesCr | 41 | 41 | 3 | 3 | 4 | 1 | 1 | 5 | 0 | 0 | 0 | 0 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 5 | 7 | 18 | 24 | 14 | 15 | 9 | 10 | 7 | 4 | 4 | 3 |
Non Current Assets Non Current AssetsCr | 13 | 13 | 10 | 10 | 10 | 9 | 5 | 8 | 7 | 6 | 7 | 6 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | -4 | 0 | 4 | -7 | 9 | 3 | 2 | -5 | -3 | 1 | 0 |
Investing Cash Flow Investing Cash FlowCr | -1 | -1 | -1 | -1 | -1 | -1 | 0 | 10 | 4 | 0 | 0 |
Financing Cash Flow Financing Cash FlowCr | 5 | 1 | 0 | 5 | -8 | -3 | -2 | -5 | -2 | -1 | 0 |
|
Free Cash Flow Free Cash FlowCr | -5 | -1 | 3 | -7 | 8 | 3 | 2 | -7 | -2 | 1 | 0 |
| -411.4 | 4.8 | 83.0 | -88.0 | 331.6 | -1,036.8 | 1,270.5 | -54.0 | -95.5 | -108.2 | -92.8 |
CFO To EBITDA CFO To EBITDA% | 407.9 | 3.9 | 58.8 | -80.5 | 254.3 | 841.3 | -274.9 | 518.0 | -1,536.6 | -70.0 | 144.9 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 1 | 3 | 8 | 33 | 23 | 9 | 11 | 18 | 14 | 18 | 9 |
Price To Earnings Price To Earnings | 1.5 | 1.0 | 1.6 | 4.3 | 8.7 | 0.0 | 82.9 | 1.9 | 4.9 | 0.0 | 39.8 |
Price To Sales Price To Sales | 0.1 | 0.1 | 0.2 | 0.6 | 0.5 | 0.3 | 0.5 | 1.3 | 0.9 | 1.7 | 0.9 |
Price To Book Price To Book | 0.0 | -0.1 | -0.3 | -1.9 | -2.2 | -0.9 | -1.1 | -33.7 | 6.3 | 10.4 | 4.5 |
| -33.0 | 8.8 | 4.9 | 6.9 | 10.9 | 56.1 | -36.0 | -24.8 | 110.0 | -30.2 | -97.3 |
Profitability Ratios Profitability Ratios |
| 45.6 | 46.2 | 46.5 | 48.3 | 43.6 | 45.5 | 39.1 | 36.2 | 28.0 | 27.4 | 34.0 |
| -5.0 | 14.0 | 16.2 | 16.2 | 7.9 | 1.3 | -2.8 | -7.3 | 1.1 | -7.3 | -1.5 |
| 5.0 | 11.6 | 11.5 | 14.8 | 6.0 | -1.0 | 0.6 | 69.7 | 17.8 | -4.7 | 2.3 |
| -38.9 | -212.1 | 424.3 | 98.2 | 63.4 | -1.9 | 58.5 | 148.1 | 40.2 | -6.7 | 5.5 |
| -2.6 | -9.7 | -17.5 | -44.4 | -25.4 | 3.0 | -1.3 | -1,795.4 | 127.3 | -28.2 | 11.4 |
| 5.3 | 16.5 | 17.6 | 22.4 | 11.0 | -1.3 | 0.9 | 55.8 | 21.0 | -4.6 | 2.2 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
**Lime Chemicals Limited** is a veteran player in the Indian industrial minerals sector, specializing in the production and distribution of **Precipitated and Coated Calcium Carbonate (PCC)**. Established in **1976**, the company has historically served as a critical supply chain partner for the pharmaceutical, consumer goods, and construction industries. Currently, the company is navigating a high-stakes operational pivot, transitioning from a traditional manufacturing-heavy model to a lean, sourcing-led hybrid strategy to address financial pressures and negative net worth.
---
### **Strategic Pivot: Transition to a Hybrid Sourcing Model**
Following a comprehensive business re-organization, Lime Chemicals has shifted its operational focus to improve agility and reduce fixed overheads.
* **Asset Rationalization:** In **December 2022**, the company sold its **Roha Factory Building** and land for **₹5.1 crore**, realizing a profit of **₹3.09 crore**. This was a precursor to a broader exit from direct manufacturing at underperforming sites.
* **Plant Closure (Sidhpur):** In **December 2024**, the company shuttered its leased manufacturing facility in **Sidhpur, Gujarat**, citing non-viability.
* **Current Sourcing Strategy:** The company now operates via a hybrid model, sourcing manufactured products through strategic arrangements with **group companies** and third-party providers from new premises in **Abu Road, Rajasthan**.
* **Future Manufacturing Optionality:** While currently focused on trading and outsourced sourcing, the company retains land in **Kala Amb, Dist. Jagadhri, Haryana**. This site is earmarked for the potential re-establishment of direct manufacturing should market conditions and internal liquidity improve.
---
### **Product Portfolio & Industrial Value Chain**
Lime Chemicals produces and deals in two primary forms of Calcium Carbonate, distinguished by their processing methods and end-use purity.
| Product Category | Key Characteristics | Primary Industrial Applications |
| :--- | :--- | :--- |
| **Precipitated Calcium Carbonate (PCC)** | Chemically synthesized; high purity; controlled particle size. | **Toothpaste, Pharmaceuticals**, PVC, Rubber, Polymers, and Paints. |
| **Ground Calcium Carbonate (GCC)** | High **brightness (whiteness)**; derived from natural limestone. | **Paper**, Plastics, Adhesives, and **Building/Construction** materials. |
**Key Market Drivers:**
* **Construction & Infrastructure:** Products are essential for **vinyl floor tiles**, **asphalt roofing**, concrete, and masonry.
* **Consumer Essentials:** High-purity grades are critical inputs for the **Pharmaceutical** and **Oral Care (Toothpaste)** sectors.
* **Industrial Fillers:** Used extensively as extenders in the **Paper** and **Paint** industries to enhance opacity and reduce production costs.
* **Raw Material Dependency:** The company relies on **imported high-quality limestone** to meet stringent customer specifications regarding chemical purity and whiteness.
---
### **Financial Performance & Capital Structure**
The company is currently classified as a **sick company** under financial stress, with a focus on stabilizing a balance sheet characterized by **negative net worth** and accumulated losses.
**Comparative Financial Snapshot (₹ in Lakhs)**
| Metric | FY 2023-24 | FY 2022-23 |
| :--- | :--- | :--- |
| **Gross Income** | **1,085.00** | **1,560.00** |
| **Net Profit / (Loss)** | **(48.57)** | **(0.66)** |
| **Total Comprehensive Income** | **(51.55)** | **271.00** |
| **Domestic Sales** | **1,045.47** | **1,535.24** |
| **Export Sales** | **0.00** | **12.55** |
**Solvency and Liquidity Metrics**
* **Revenue Contraction:** Gross income declined by **33.65%** in the most recent full fiscal year.
* **Capital Gearing:** The **Capital Gearing Ratio** stood at **2.87** as of March 2025, reflecting high leverage.
* **Working Capital Deficit:** As of March 2024, current liabilities (**₹8.66 crore**) significantly exceeded current assets (**₹4.07 crore**), resulting in a negative working capital of **₹(4.59) crore**.
* **Debt Management:** Total debt was **513.35 Lakhs** as of March 2025. The company relies on funding from **Executive Directors** to bridge working capital gaps.
* **Dividend Status:** No dividends have been recommended for the last **three years** due to persistent losses.
---
### **Governance, Compliance & Leadership**
The company is undergoing a leadership and administrative refresh to align with **SEBI (LODR) Regulations, 2015**.
* **Leadership Changes:** **Mrs. Rutuja Shinde** was appointed as **CFO** effective **March 07, 2026**. Additionally, **Mr. Rahim Narsingdani** joined as an **Additional Non-Executive Independent Director** for a **5-year** term.
* **Corporate Relocation:** The Board approved shifting the **Registered Office** from CBD Belapur to **Vile Parle West, Mumbai**, moving the company under the jurisdiction of **ROC Mumbai I**.
* **Internal Controls:** The company maintains an **ISO 9001** certification. Internal Audit functions report directly to the **Chairman of the Audit Committee**.
* **Operational Transparency:** The company does **not accept fixed deposits**, owns **no intangible assets**, and has **no subsidiaries** or joint ventures as of late 2025.
---
### **Risk Factors & Contingent Liabilities**
Investors should note significant legal and macro-economic risks that could impact the "Going Concern" status of the company.
**1. Litigation and Tax Demands**
The company is contesting several high-value claims:
* **GST Demands:** **₹1.85 Crore** (Maharashtra) and **₹1.44 Crore** (Himachal Pradesh).
* **Employees P.F.:** Disputed claims of **₹138.62 Lakhs**.
* **Income Tax:** Outstanding demand of **₹57.27 Lakhs** for **A.Y. 2006-07**.
* **MSME Dispute:** A quality dispute with a raw material vendor has led to an unprovided interest liability of **₹35.35 Lakhs** to **₹36.25 Lakhs**.
**2. Operational & Macro Risks**
* **Logistics Costs:** Limestone reserves are geographically concentrated; high **transportation costs** for bulky raw materials weigh on margins.
* **Input Volatility:** Exposure to **foreign exchange fluctuations** (due to imported limestone) and price volatility in **stearic acid** and **calcite powder**.
* **Regulatory Changes:** The implementation of **New Labour Codes** (effective Nov 2025) regarding wages and gratuity has not yet been financially provisioned.
* **Competitive Pressure:** Intense rivalry from both large-scale organized manufacturers and low-cost unorganized local players.
**3. Mitigation Strategy**
To counter these risks, management is pursuing **price renegotiations** with key customers to pass through raw material hikes, implementing **strict credit limits** to manage counterparty risk, and executing **cost-reduction plans** to stabilize the negative net worth.